secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aura Biosciences, Inc. (AURA)
CIK:        0001501796
Form:       8-K
Filed at:   2025-04-02T23:59:59+00:00
Accession:  0000950170-25-048880
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aura Biosciences appoints Teresa Bitetti to Board of Directors
--------------------------------------------------------------

- Teresa Bitetti appointed as Class II director effective March 31, 2025, filling newly created vacancy.
- Bitetti is President of Global Oncology at Takeda; also appointed to Compensation Committee.
- Received initial stock option for 29,000 shares and RSU for 21,000 shares, vesting over 3 years.
- Board size increased from six to seven directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501796/000095017025048880/0000950170-25-048880-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501796/000095017025048880/aura-20250331.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-048880

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer